In recent years, the CRISPR/Cas9 system has been successfully utilized for efficient genome editing in various eukaryotic organisms ([@bib44]; [@bib11]; [@bib48]). This system usually contains two components: one is the Cas9 protein; the other is a single-guide RNA (sgRNA), which is composed of a scaffold sequence for Cas9-binding and a user-defined 20-nucleotide target sequence. Together, Cas9 and sgRNA form an RNA-guided endonuclease that creates a double-strand break (DSB) in the target DNA 3 bp upstream of the protospacer‐adjacent motif (PAM), which is NGG for the most commonly used Cas9 protein from *Streptococcus pyogenes* ([@bib27]). During the repair of the Cas9-generated DSBs, the desired genome editing outcomes can be achieved through either random mutations introduced by the error-prone non-homologous end joining (NHEJ) pathway or precise mutations introduced by the homologous recombination (HR) pathway ([@bib44]).

In deploying the CRISPR/Cas9 system, the expression of the sgRNA poses a special challenge, because the most commonly used promoters, which are RNA polymerase II-transcribed, do not allow the production of sgRNAs with precise 5′ end and 3′ end. For this reason, sgRNAs have usually been expressed from RNA polymerase III-transcribed promoters ([@bib32]). However, RNA polymerase III-transcribed promoters are not well characterized in many organisms and often require particular nucleotides at the 5′ end of sgRNAs ([@bib16]; [@bib44]). In fission yeast, this challenge has been solved elegantly by the combined use of the promoter/leader sequence of a RNA polymerase II-transcribed RNA-encoding gene, *rrk1*, and a self-cleavage hammerhead ribozyme ([@bib24]).

In the published procedures of applying the CRISPR/Cas9 technology in fission yeast, a plasmid-cloning step is always undertaken each time a new sgRNA is needed ([@bib24]; [@bib39]; [@bib14]). This step is a multi-day endeavor that includes manipulations of DNA, transforming *E. coli* cells, plasmid preparation, and plasmid verification by sequencing. Because the cloned plasmid is destined to be delivered into the fission yeast cells and likely serves no further use once the intended genome editing is achieved, we envisioned that the cloning step can be omitted by assembling the Cas9-sgRNA plasmid through the highly efficient *in vivo* gap repair process in the fission yeast cells ([@bib30]; [@bib29]; [@bib8]; [@bib36]; [@bib6]). In this work, we designed and implemented a gap-repair-based and cloning-free procedure for applying the CRISPR/Cas9 technology in fission yeast. We validated its use in point mutation knock-in, endogenous N-terminal tagging, and genomic sequence deletion.

Materials and Methods {#s1}
=====================

Fission yeast strains and culturing conditions {#s2}
----------------------------------------------

The fission yeast strain LD260 (*h^-^ ura4-D18 leu1-32 his3-D1*) was from our laboratory strain collection, and the naturally isolated strain JB938 was acquired from the Yeast Genetic Resource Center of Japan (YGRC/NBRP) (<http://yeast.nig.ac.jp/>) ([@bib25]). Cells were cultured in pombe minimal medium with glutamate (PMG), or a yeast extract-based rich medium (YES) at 30° or other temperatures as noted. The compositions of these media and standard genetic methods were as described ([@bib15]).

Plasmid construction {#s3}
--------------------

Plasmids used in this study are listed in [Table 1](#t1){ref-type="table"}, and primers used for plasmid construction are listed in Table S1.

###### Plasmids used in this study

  Plasmid     Description                                                                                                                                                                                                                                              Addgene ID
  ----------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  pMZ374      A Cas9-encoding plasmid that contains an intact *ura4* marker, and is used in cloning-based procedures ([@bib24]).                                                                                                                                       59896
  pDB4280\*   A Cas9-encoding plasmid containing the 5′ portion of the *ura4* marker and the *rrk1* promoter/leader. When linearized by *Not*I, the resultant 10,201-bp DNA serves as the gapped plasmid in the split-*ura4* system.                                   98699
  pDB4282\*   A plasmid containing the 3′ portion of the *ura4* marker and the sgRNA elements downstream of the target sequence. When digested by *Not*I, a 1,354-bp fragment serves as the PCR template for generating the sgRNA insert in the split-*ura4* system.   98701
  pDB4279\*   A pMZ374-derived plasmid with the *ura4* marker changed to the *bsdMX* marker.                                                                                                                                                                           98698
  pDB4281\*   A Cas9-encoding plasmid containing the 5′ portion of the *bsdMX* marker and the *rrk1* promoter/leader. When linearized by *Not*I, the resultant 9,800-bp DNA serves as the gapped plasmid in the split-*bsdMX* system.                                  98700
  pDB4283\*   A plasmid containing the 3′ portion of the *bsdMX* marker and the sgRNA elements downstream of the target sequence. When digested by *Not*I, a 931-bp fragment serves as the PCR template for generating the sgRNA insert in the split-*bsdMX* system.   98702
  pDB4284\*   An *rpl42*-targeting Cas9-sgRNA plasmid generated by cloning.                                                                                                                                                                                            

The plasmids constructed in this study are indicated by an asterisk.

We constructed two plasmids for the split-*ura4* system. For the first plasmid (pDB4280), we modified the plasmid pMZ374 ([@bib24]), by replacing a 1,191-bp sequence between the *rrk1* promoter/leader and the 160^th^ codon of *ura4* gene with a *Not*I site using the Quikgene method with oligos P127 and P128 ([@bib35]). For the second plasmid (pDB4282), a 1,324-bp sequence containing the 3′ part of the *ura4* marker starting from the 108^th^ codon, the hammerhead ribozyme coding sequence, and the sgRNA scaffold sequence, was amplified from pMZ374 using oligos P75 and P82, and then cloned into the pEASY-blunt vector (Transgene, China).

For the split-*bsdMX* system, we first switched the *ura4* marker in pMZ374 to a drug resistance marker *bsdMX* by gap repair in fission yeast ([@bib13]). The *bsdMX* marker, which confers blasticidin S resistance, was amplified from an MDR-supML strain provided by Shigehiro Kawashima ([@bib1]), using oligos P123 and P124, which contain sequences that base pair with sequences flanking the *ura4* marker in pMZ374 (38-bp upstream sequence and 36-bp downstream sequence). The *bsdMX* PCR product was co-transformed with *Stu*I digested pMZ374 into fission yeast cells, and the episomal plasmid rescued from a resultant blasticidin-resistant colony was named pDB4279. A 770-bp sequence between the *rrk1* promoter/leader and the 89^th^ codon of the *bsdMX* gene in pDB4279 was replaced with a *Not*I site using the Quikgene method with oligos P129 and P130. The resultant plasmid was named pDB4281. A 901-bp fragment containing the 3′ part of the *bsdMX* marker starting from the 38^th^ codon, the hammerhead ribozyme coding sequence, and the sgRNA scaffold sequence, was amplified from pDB4279 with oligos P131 and P82, and then cloned into pEASY-blunt vector (Transgene, China), generating the pDB4283 plasmid.

Preparation of the gapped plasmid {#s4}
---------------------------------

For the split-*ura4* system, a gapped plasmid (10,201 bp) containing the Cas9-coding sequence and the 5′ part of the *ura4* marker was generated by linearizing pDB4280 with *Not*I digestion.

For the split-*bsdMX* system, a gapped plasmid (9,800 bp) that contains the Cas9-coding sequence and the 5′ part of the *bsdMX* marker was generated by linearizing pDB4281 with *Not*I digestion.

Preparation of the PCR templates for sgRNA insert amplification {#s5}
---------------------------------------------------------------

For the split-*ura4* system, the PCR template (1,354 bp) for amplifying sgRNA inserts was generated from pDB4282 by *Not*I digestion. The template contains the 3′ part of the *ura4* marker, the hammerhead ribozyme sequence, and the sgRNA scaffold sequence, but not the sgRNA target sequence and the *rrk1* promoter/leader sequence.

For the split-*bsdMX* system, the PCR template (931 bp) for amplifying sgRNA inserts was generated from pDB4283 by *Not*I digestion. The template contains the 3′ part of the *bsdMX* marker, the hammerhead ribozyme sequence, and the sgRNA scaffold sequence, but not the sgRNA target sequence and the *rrk1* promoter/leader sequence.

Target sequence selection {#s6}
-------------------------

The sgRNA target sequence is the 20 nucleotides upstream of the PAM sequence, which is NGG, where N is any nucleotide ([@bib27]). When more than one NGG sequence can suit the need of genome editing, sgRNA target sequences were selected based on their "on-target scores" calculated by an sgRNA designing software at benchling.com ([@bib10]). In our experience, a high "on-target score" did not always translate into a high editing efficiency. Thus, if possible, we usually chose two different sgRNA target sequences for each editing task. The sgRNA target sequences used in this study are listed in [Table 2](#t2){ref-type="table"}.

###### Genome editing performed in this study

  Target locus           Intended editing outcome              sgRNA target sequence (5′-3′)   PAM (5′-3′)   On-target score\*   Distance between cleavage site and editing site
  ---------------------- ------------------------------------- ------------------------------- ------------- ------------------- -------------------------------------------------
  *rpl42*                P56Q mutation                         TTAGCCTTCTTGTGGAAAAC            GGG           39.2                3 bp
  *tor2*                 L2048S mutation                       AGGCCTTTTAGGCTGGGTTT            TGG           34.1                18 bp
  TATCCAAAACCCAGCCTAAA   AGG                                   36.3                            26 bp                             
  *cdc25*                C532Y mutation                        CGTAGTTAATTGGGTCACAA            CGG           66.2                0 bp
  TTGGGTCACAACGGTTTTTG   TGG                                   43.5                            8 bp                              
  *ypt7*                 N-terminally tagging with mECitrine   TTTTACGCTGTAAATATGGC            CGG           55.3                2 bp
  TCGTTTTTACGCTGTAAATA   TGG                                   30.6                            2 bp                              
  *mat1*                 140-bp deletion                       TCTCGTTAGAGGGAAGGGGA            AGG           65.3                N/A
  CACAAAAAGGGAAAATTGGA   GGG                                   63.2                            N/A                               

On-target scores of sgRNAs were calculated using the sgRNA design software at the benchling.com website.

sgRNA insert amplification {#s7}
--------------------------

The sgRNA target sequence (5′-3′) was incorporated into a 83-nt sgRNA primer (5′-ATAGTTGCTGTTGCCAAAAAACATAACCTGTACCGAAGAA*NNNNNNNNNNNNNNNNNNNN*gttttagagctagaaatagcaag-3′), which contains a 40-nt sequence (in capital letters) from the *rrk1* leader, followed by the 20-nt sgRNA target sequence (shown as 20 Ns in italic), and a 23-nt sequence from the sgRNA scaffold sequence (in lower case letters).

Using a high-fidelity DNA polymerase, a common primer (P75, 5′-CATCTGGTGTGTACAAAATTG-3′, for the split-*ura4* system, or P131, 5′-GGCCGCATCTTCACTGGTGTC-3′, for the split-*bsdMX* system) was paired with the sgRNA primer to amplify the sgRNA insert from the PCR template aforementioned. To facilitate gap repair, the sgRNA insert ends with sequences that overlap with the terminal sequences of the gapped plasmid. For the split-*ura4* system, the sgRNA insert (1,375 bp) contains a 158-bp overlapping sequence (in the *ura4* selection marker) at one end and a 40-bp overlapping sequence (in the *rrk1* leader) at the other end. For the split-*bsdMX* system, the sgRNA insert (952 bp) contains a 156-bp overlapping sequence (in the *bsdMX* selection marker) at one end and a 40-bp overlapping sequence (in the *rrk1* leader) at the other end.

Design of donor DNA {#s8}
-------------------

To achieve a precise genome-editing outcome, we used donor DNA carrying the intended mutation and if the intended mutation does not abolish Cas9 cleavage, at least one additional synonymous cleavage-blocking mutation locating in the last 10 nucleotides of the sgRNA target sequence or in the PAM sequence. For knock-in or knock-out, the donor DNA was provided as a pair of 90-nt synthetic oligos whose sequences are reverse complementary to each other. For knock-in, the desired mutation(s) were placed approximately in the middle of the 90-nt sequence. For knock-out, two 45-bp sequences flanking the region to be deleted were joined together to serve as the donor. For N-terminal tagging, the donor DNA was provided as a PCR product, which contains homology arm sequences flanking the tag sequence. The donor oligos and primers used in this study are listed in Table S2.

Transformation, selection, and phenotype assessment {#s9}
---------------------------------------------------

The gapped plasmid, the sgRNA insert PCR product, and the donor DNA (two 90-nt synthetic oligos or a PCR product) were co-transformed into an appropriate fission yeast strain using the lithium acetate/single-stranded carrier DNA/polyethylene glycol method ([@bib18]). The split-*ura4* system requires the host strain to harbor the *ura4-D18* allele, which is a complete deletion of the sequence in the *ura4* marker ([@bib20]). The split-*bsdMX* system requires the host strain to not already have a blasticidin S resistance marker. 5 OD600 units of cells were used in each transformation (One OD600 unit is the amount of cells, which, if resuspended in 1 ml water would give an OD600 of 1; one OD600 unit corresponds to approximately 10^7^ cells). A donor-free transformation was always included as a control to assess the effect of the donor on the transformation efficiency. A strong donor-dependent increase of transformation efficiency usually correlated with high genome editing efficiency. Another useful control is the co-transformation of the gapped plasmid with an sgRNA insert amplified using a control sgRNA primer. We used 5′-ATAGTTGCTGTTGCCAAAAAACATAACCTGTACCGAAGAA*tgggcttaactcaattcttgtgggttatctctct*gttttagagctagaaatagcaag-3′ as the control sgRNA primer to amplify a control sgRNA insert, which through gap repair generates a plasmid identical to pMZ374 for the split-*ura4* system or pDB4279 for the split-*bsdMX* system, respectively, and does not express any gene-targeting sgRNA. Compared to the donor-free transformation of the gapped plasmid with a gene-targeting sgRNA insert, this control should yield a much higher transformation efficiency due to the lack of Cas9 cleavage of the genome (Figure S1). Ineffective gene-targeting sgRNA can result in a similarly high transformation efficiency in the absence of the donor DNA.

For the split-*ura4* system, uracil prototrophic transformants were selected on PMG plates with necessary supplements but lacking uracil. Colonies usually formed after incubating at 30° for 6-8 days. This longer than usual time taken for transformant colonies to form is due to the growth inhibitory effect of Cas9 on fission yeast cells ([@bib24]).

For the split-*bsdMX* system, transformants were selected on YES plates supplemented with 30 µg/ml of blasticidin S hydrochloride (Wako Pure Chemical Industries, Ltd., catalog number 029-18701). To enhance the transformation efficiency, instead of the common practice of plating cells onto YES prior to replica-plating onto selective media for antibiotic marker selection, we performed a liquid phase recovery in MSL-N liquid medium for 24 hr prior to plating on blasticidin-containing plates ([@bib13]). Colonies usually formed after incubating at 30° for 4-6 days.

The correct genome editing outcomes were scored by assessing the expected phenotypes of the intended mutations. For the *rpl42-P56Q* mutation, the expected resistance to cycloheximide (CYH) was assessed by replica plating onto YES plates containing 100 µg/ml of CYH; For *tor2-L2048S* and *cdc25-C532Y* mutations, the expected temperature-sensitive phenotype was analyzed by replica-plating onto two YES plates and then incubating one of them at the permissive temperature (25°) and the other at the restrictive temperature (36°). For N-terminal tagging of Ypt7 with a fluorescent protein, the clones were grown in liquid PMG medium containing necessary supplements and then observed with microscope. For converting a homothallic *h90* strain to heterothallic strains by introducing the *mat1-∆17* mutation ([@bib2]), the transformants were replica plated onto SPAS plates with necessary supplements to induce mating, meiosis, and sporulation, and then stained with iodine vapor, which stains spores dark brown ([@bib15]).

As has been observed by others ([@bib24]; [@bib39]), the rare fast-growing transformant colonies, which appeared to have escaped from the growth inhibitory effect of Cas9, usually do not harbor the intended genome-editing outcome, probably because Cas9 is absent or not functional in these clones. Such colonies were avoided when picking random colonies for phenotype assessment (*e.g.*, in the case of Ypt7 tagging), and were not counted when quantitating transformation and genome editing efficiencies.

Because of the growth inhibitory effect of Cas9 on fission yeast cells, the removal of the episomal Cas9-sgRNA plasmid can be quickly achieved by growing the transformant clones on a non-selective medium.

Light microscopy {#s10}
----------------

Live cell imaging was performed using a DeltaVision PersonalDV system (Applied Precision) equipped with a CFP/YFP/mCherry filter set (Chroma 89006 set) and a Photometrics CoolSNAP HQ2 camera. Images were acquired with a 100× 1.4-NA objective lens and were analyzed with the softWoRx program.

Reagent and data availability {#s11}
-----------------------------

Five plasmids created in this study (pDB4279, pDB4280, pDB4281, pDB4282, and pDB4283) have been deposited at Addgene (Addgene plasmid number 98698, 98699, 98700, 98701, and 98702, respectively). Plasmid map files in GenBank format are provided as Files S1-S5 uploaded to GSA figshare portal. Other supplementary files uploaded to GSA figshare portal include Figures S1--S7 and Tables S1--S3. Supplemental material available at Figshare: <https://doi.org/10.25387/g3.6133217>.

Results {#s12}
=======

A gap-repair-based CRISPR/Cas9 procedure can efficiently knock in a point mutation in fission yeast {#s13}
---------------------------------------------------------------------------------------------------

To make the CRISPR/Cas9 system more efficient in fission yeast, we developed a cloning-free procedure, which assembles the Cas9-sgRNA plasmid by gap repair in fission yeast cells ([Figure 1](#fig1){ref-type="fig"}). We call one version of this procedure the split-*ura4* system, which utilizes two plasmids pDB4280 and pDB4282 ([Table 1](#t1){ref-type="table"}), both derived from the *ura4*-marked plasmid pMZ374 ([@bib24]). Digesting these two plasmids with *Not*I generates the gapped plasmid and the PCR template for sgRNA insert amplification, respectively. Using a common primer and an 83-nt sgRNA-specific primer to perform PCR, an sgRNA insert containing a specific target sequence is generated by PCR amplification. At the two ends of an sgRNA insert are sequences overlapping with the gapped plasmid. Upon co-transformation of the gapped plasmid and the sgRNA insert into a *ura4-D18* fission yeast strain, a plasmid expressing both Cas9 and sgRNA is assembled *in vivo* by gap repair. Importantly, neither the gapped plasmid nor the sgRNA insert has a complete *ura4* marker, so that only the correctly assembled plasmid can result in the transformation of a uracil auxotrophic *ura4-D18* strain to a uracil prototrophic one. If provided with an appropriate donor DNA for homologous recombination-mediated repair of the Cas9-induced DSB, this cloning-free CRISPR/Cas9 procedure should permit rapid and precise genome editing.

![The cloning-free procedure that generates the Cas9-sgRNA plasmid through gap repair. In this procedure, the sgRNA target sequence, depicted in red, is synthesized as part of an 83-nt oligo (sgRNA primer), then incorporated into a linear DNA fragment (sgRNA insert) by PCR, and eventually recombined into a circular plasmid by gap repair in fission yeast cells. The overlapping sequences involved in gap repair are indicated by the crossed dashed lines. To prevent gap-repair-independent transformation, the gapped plasmid and the sgRNA insert contain only the 5′ and the 3′ parts of the selection marker, respectively. Only proper gap repair can reconstitute the complete marker (*ura4* in the split-*ura4* system and *bsdMX* in the split-*bsdMX* system). The split-*ura4* system is depicted here (not drawn to scale).](2067f1){#fig1}

To test this procedure, we used it to knock-in the *rpl42-P56Q* mutation, which is known to confer cycloheximide resistance (CYH^R^) ([@bib46]; [@bib40]). The nucleotides to be mutated (a CCC codon for proline) coincide with a PAM sequence (GGG on the opposite strand), and thus we were able to use an sgRNA that induces Cas9 cleavage only 3 bp away from the editing site ([Figure 2A](#fig2){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). Ura^+^ transformant colonies that contain the knock-in mutation were identified by replica plating transformant colonies onto YES plates containing CYH ([Figure 2B](#fig2){ref-type="fig"}). The ratio of the number of CYH^R^ colonies to the number of Ura^+^ transformant colonies (CYH^R^/Ura^+^) was taken as the knock-in or editing efficiency. Using a pair of 90-nt complementary oligos as donor DNA, the gap repair procedure achieved a high editing efficiency (84%), comparable to that obtained using a cloned Cas9-sgRNA plasmid ([Figure 2B](#fig2){ref-type="fig"} and [2C](#fig2){ref-type="fig"}). The presence of donor DNA was not only critical for the knock-in to occur, but also notably increased the transformation efficiency, presumably because the knock-in mutation blocks Cas9-mediated DNA cleavage, which is detrimental to the cells. Unexpectedly, the gap repair procedure resulted in more than 10-fold higher transformation efficiencies than the procedure using the cloned plasmid. The exact reason behind this phenomenon is unclear.

![Knock-in of the *rpl42-P56Q* mutation using the split-*ura4* system. A. Sequences of the *rpl42* gene and the donor DNA for introducing the *rpl42-P56Q* mutation. In the *rpl42* sequence, the PAM sequence is shaded in gray and the two invariable guanines in the PAM are highlighted in magenta, the sgRNA target sequence is indicated by a red arrow, and the cleavage site is indicated by a black arrowhead. The editing site (codon to be changed by the knock-in) is boxed. In the donor DNA sequence, the altered nucleotides are highlighted in blue and the altered codon is boxed. T171G is a silent mutation designed to increase the chance of the *rpl42-P56Q* mutation being incorporated during homologous recombination. However, we later found that a donor without the T171G mutation was equally effective in knocking in the *rpl42-P56Q* mutation (data not shown). B. Representative plate images from an *rpl42-P56Q* knock-in experiment using the split-*ura4* system. The images at the top show the Ura^+^ transformant colonies formed on selective plates lacking uracil, and the images at the bottom show the CYH^R^ colonies formed after replica plating transformant colonies onto YES plates containing cycloheximide (CYH, 100 µg/ml). A small transformant colony with the desired genome editing outcome (CYH^R^) is indicated by a green arrowhead, and a rare large transformant colony without the desired genome editing outcome is indicated by a red arrowhead. Only small colonies were considered when calculating the transformation efficiency and the editing efficiency. PCR and Sanger sequencing analysis of 16 CYH^R^ colonies confirmed the presence of the *rpl42-P56Q* mutation in all of their genomes. C. Quantitation of the editing efficiencies and the transformation efficiencies of the *rpl42-P56Q* knock-in experiments. Cas9 and sgRNA were introduced into the cells using either the gap repair procedure (split-*ura4* system, 30 ng of the gapped plasmid and 200 ng of the sgRNA insert) or a cloned Cas9-sgRNA plasmid pDB4284 (30 ng). Donor DNA was provided as two 90-nt complementary oligos (0.3 nmol each). Transformation efficiencies were expressed as colony forming units (CFU) per OD600 unit of cells. Editing efficiencies were expressed as percentages of Ura^+^ transformant colonies that are also CYH^R^. Error bars represent the standard deviation from at least three biological replicates.](2067f2){#fig2}

We varied the amounts of the gapped plasmid and the sgRNA insert used per transformation (Figure S2), and found that, taking into account the editing efficiency, the total yield of edited clones, and the reagent cost, 30 ng of the gapped plasmid and 200 ng of the sgRNA insert are an optimal pair of parameters, corresponding to a molar ratio of approximately 1:50, a ratio in line with previous reports on optimal gap repair parameters ([@bib12]; [@bib36]). We used such amounts for all ensuing experiments.

Both single-stranded and double-stranded oligos have been used as donor DNA for knocking in mutations ([@bib47]; [@bib5]; [@bib9]). We found that a single 90-nt donor oligo, either the sense oligo or the antisense oligo, can serve as donor to knock in the *rpl42-P56Q* mutation, but knock-in efficiencies were markedly lower than when both oligos were provided together (Figure S3). A high level of knock-in efficiency was obtained when the two oligos were simply added together into the transformation mix without prior denaturing or annealing (Figure S3). When varying amounts of donor DNA were tested, we observed that both the editing efficiency and the transformation efficiency increased with the amount of donor DNA up to 0.3 nmol of each oligo, the maximal amount examined (Figure S4). For economic considerations, we chose to use 0.3 nmol each of two 90-nt complementary oligos for all ensuing knock-in experiments, even though this amount may not be saturating.

The split-*bsdMX* system increases the flexibility of the cloning-free procedure {#s14}
--------------------------------------------------------------------------------

To broaden the utility of the gap-repair based procedure beyond *ura4-D18* strains, we developed another version of it, called the split-*bsdMX* system, which utilizes the blasticidin S resistance selection marker *bsdMX*. In this system, two plasmids pDB4281 and pDB4283 serve as the sources of the gapped plasmid and the template for amplifying the sgRNA insert, respectively ([Table 1](#t1){ref-type="table"}). Using the *rpl42-P56Q* knock-in again as a proof-of-principle test, we found that the split-*bsdMX* system achieved an editing efficiency comparable to that obtained with the split-*ura4* system, albeit with a notably lower transformation efficiency ([Figure 3](#fig3){ref-type="fig"}).

![Knock-in of the *rpl42-P56Q* mutation using the split-*bsdMX* system. A. Representative plate images from an *rpl42-P56Q* knock-in experiment using the split-*bsdMX* system. The images at the top show the bsd^R^ transformant colonies formed on YES plates containing blasticidin (bsd, 30 µg/ml), and the images at the bottom show the CYH^R^ colonies formed after replica plating transformant colonies onto YES plates containing CYH (100 µg/ml). A small transformant colony with the desired genome editing outcome (CYH^R^) is indicated by a green arrowhead, and a rare large transformant colony without the desired genome editing outcome is indicated by a red arrowhead. Only small colonies were considered when calculating the transformation efficiency and the editing efficiency. B. Quantitation of the editing efficiencies and the transformation efficiencies of a representative *rpl42-P56Q* knock-in experiment using the split-*bsdMX* system. 30 ng of the gapped plasmid and 200 ng of the sgRNA insert were used. Donor DNA was provided as two 90-nt complementary oligos (0.3 nmol each).](2067f3){#fig3}

Knock-in of two temperature-sensitive mutations using the cloning-free procedure {#s15}
--------------------------------------------------------------------------------

To test the versatility and generality of the cloning-free procedure, we applied the split-*ura4* system to knock in two temperature-sensitive (ts) mutations: *tor2-L2048S (tor2-287)* ([@bib21]) and *cdc25-C532Y (cdc25-22)* ([@bib42]; [@bib37]). Two different sgRNAs were chosen for each mutation ([Figure 4A](#fig4){ref-type="fig"}, [4B](#fig4){ref-type="fig"}, and [Table 2](#t2){ref-type="table"}). One pair of 90-nt complementary oligos that contains two PAM-disrupting silent mutations was used as the donor DNA for each mutation ([Figure 4A](#fig4){ref-type="fig"}, [4B](#fig4){ref-type="fig"}, and Table S2).

![Knock-in of two temperature-sensitive mutations using the split-*ura4* system. A and B. Sequences of the target gene (*tor2* in A and *cdc25* in B) and the donor DNA for introducing a temperature-sensitive (ts) mutation (*tor2-L2048S* in A and *cdc25-C532Y* in B). PAM sequences are shaded in gray; the invariable guanines in the PAMs are highlighted in magenta. The sgRNA target sequences are indicated by red arrows, and the cleavage sites are indicated by black arrowheads. The editing site (codon to be changed by the knock-in) is boxed. In the donor DNA sequence, the altered nucleotides are highlighted in blue and the altered codon is boxed. C6111A and G6129A in *tor2* and C1581T and C1590T in *cdc25* are cleavage-blocking silent mutations that disrupt the PAMs but do not change the amino acid sequences. C. Quantitation of the editing efficiencies and the transformation efficiencies of the *tor2-L2048S* knock-in. PCR and Sanger sequencing analysis of 11 temperature-sensitive colonies confirmed the presence of the *tor2-L2048S* mutation in all of their genomes. Error bars represent the standard deviation from at least three biological replicates. D. Quantitation of the editing efficiencies and the transformation efficiencies of the *cdc25-C532Y* knock-in. PCR and Sanger sequencing analysis of 10 temperature-sensitive colonies confirmed the presence of the *cdc25-C532Y* mutation in all of their genomes. Error bars represent the standard deviation from at least three biological replicates.](2067f4){#fig4}

Compared to the *rpl42-P56Q* knock-in, we obtained more modest levels of knock-in efficiencies (34% and 27% respectively for the two sgRNAs) when knocking in the *tor2-L2048S* mutation ([Figure 4C](#fig4){ref-type="fig"}). We suspected that the lower efficiencies may be due to the cleavage sites being farther away from the editing site (18 bp and 26 bp respectively for the two *tor2* sgRNAs *vs.* 3 bp for the *rpl42* sgRNA). Indeed, when a number of randomly selected transformants without the ts phenotype were examined by PCR and Sanger sequencing analysis, we found that nearly all them (11/11 for sgRNA1 and 7/8 for sgRNA2) harbored the PAM-disrupting silent mutation (Table S3), indicating that Cas9-mediated cleavage and donor recombination were highly efficient but the incorporation of distal mutations only occurred in a fraction of the recombination products.

Knock-in of the *cdc25-C532Y* mutation using sgRNA1 only achieved a moderate editing efficiency (16%), despite the cleavage site being immediately adjacent to the editing site, suggesting that the cleavage may be inefficient ([Figure 4D](#fig4){ref-type="fig"}). Consistent with this possibility, all 8 randomly chosen non-ts transformant clones had the wild-type *cdc25* sequence (Table S3). Even worse editing efficiency (2%) was obtained using sgRNA2, which induces cleavage 8 bp away from the editing site ([Figure 4D](#fig4){ref-type="fig"}). In this case, cleavage efficiency did not appear to be very poor, as approximately 40% (5/13) of the transformants without the ts phenotype contained the PAM-disrupting mutation (Table S3).

Besides the temperature sensitivity, the *tor2-L2048S* and *cdc25-C532Y* mutants obtained by Cas9-mediated knock-in exhibited the other expected phenotypes, including rapamycin sensitivity and short-cell morphology for the former, and cell elongation phenotype for the latter (Figure S5 and S6).

These experiments demonstrated that the cloning-free procedure is universally applicable for point mutation knock-in. Because sgRNA cleavage efficiency is variable, using more than one sgRNA is a worthwhile strategy to ensure knock-in success. Close proximity between the cleavage site and the editing site is beneficial, but not absolutely required for the Cas9-mediated knock-in of point mutations.

N-terminal tagging using the cloning-free procedure {#s16}
---------------------------------------------------

We next tested if this gap-repair-based CRISPR/Cas9 system could be used for N-terminal tagging. We chose to add an mECitrine fluorescent protein tag to Ypt7, a protein functioning in membrane fusion events involving vacuoles. Ypt7 is post-translationally modified at the C-terminus by prenylation and cannot tolerate C-terminal tagging ([@bib31]). We selected two different sgRNA target sequences, both of which are disrupted if tagging is successful ([Figure 5A](#fig5){ref-type="fig"}). Around 60% tagging efficiencies were achieved using sgRNA1 together with donor PCR products containing homology arms with lengths ranging from 50 to 200 bp ([Figure 5B](#fig5){ref-type="fig"}). In contrast, sgRNA2 completely failed to generate correctly tagged clones, reinforcing the notion that sgRNAs can be variable in their targeting efficiency. mECitrine-tagged Ypt7 obtained by Cas9-mediated tagging exhibited the expected vacuole localization when observed by live cell imaging (Figure S7) ([@bib28]).

![Tagging the N-terminus of Ypt7 using the split-*ura4* system. A. Sequences of the N-terminal region of the *ypt7* gene and the mECitrine tag. PAM sequences are shaded in gray; the invariable guanines in the PAMs are highlighted in magenta. The sgRNA target sequences are indicated by red arrows, and the cleavage sites are indicated by black arrowheads. B. Schematic of donor DNAs (not to scale) and their editing efficiencies when used with two different sgRNAs. Donor DNAs are composed of the mECitrine tag (shown in gray) and flanking homology arms (shown in light brown). The lengths of the homology arms are 200 bp, 100 bp, and 50 bp in donor a, b, and c, respectively. Editing efficiencies were assessed by live cell imaging analysis of individual Ura^+^ transformant clones. Correct editing resulted in the vacuole membrane being labeled by mECitrine (Figure S7).](2067f5){#fig5}

Genomic sequence deletion using the cloning-free procedure {#s17}
----------------------------------------------------------

Lastly, we tested whether the gap-repair based system can be used in genomic sequence deletion. We used the split-*bsdMX* system to generate the *mat1-∆17* deletion, which removes a 140-bp sequence from the *mat1* locus and converts homothallic strains that can efficiently switch mating type to heterothallic strains that cannot switch mating type ([@bib2]). Two sgRNA target sequences were chosen within the 140-bp sequence ([Figure 6A](#fig6){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). The donor DNA was a pair of 90-nt complementary oligos that each consists of two 45-nt homology arms flanking the sequence to be deleted ([Figure 6A](#fig6){ref-type="fig"}). Conversion to heterothallism was scored as bsd^R^ transformants that when replica-plated on a sporulating plate, cannot be darkly stained by iodine vapor ([Figure 6B](#fig6){ref-type="fig"}) ([@bib15]). Greater than 90% conversion efficiencies were achieved on JB938, a natural isolate of *S. pombe* ([Figure 6B](#fig6){ref-type="fig"} and [6C](#fig6){ref-type="fig"}), demonstrating the utility of the split-*bsdMX* system in editing the genomes of non-laboratory *S. pombe* strains, which have become increasingly useful for genetic and evolutionary studies ([@bib25]; [@bib23]).

![Use of the split-*bsdMX* system in genomic sequence deletion. A. Schematic of the *mat1* locus of a homothallic strain and the donor for generating the *mat1-∆17* deletion (not to scale). Two PAM sites were chosen within the to-be-deleted 140-bp sequence, which is situated between the H1 homology box and an *Ssp*I restriction site. Two 90-nt complementary oligos each composed of two 45-nt sequences flanking the 140-bp sequence were used as the donor. B. Representative plate images from a *mat1-∆17* deletion experiment using the split-*bsdMX* system. The parental strain is JB938, a homothallic *S. pombe* natural isolate ([@bib25]). The images at the top show the bsd^R^ transformant colonies formed on YES plates containing blasticidin (bsd, 30 µg/ml), and the images at the bottom show the iodine staining of transformant colonies replica-plated on sporulation plates (SPAS). A small transformant colony with the desired genome editing outcome (iodine-negative, *i.e.*, cannot be darkly stained by iodine vapor) is indicated by a green arrowhead, and a rare large transformant colony without the desired genome editing outcome is indicated by a red arrowhead. Only small colonies were considered when calculating the transformation efficiencies and the editing efficiencies. C. Quantitation of the editing efficiencies and the transformation efficiencies of the *mat1-∆17* deletion in JB938. PCR and Sanger sequencing analysis of 8 iodine-negative colonies confirmed the presence of the *mat1-∆17* deletion in their genomes. Error bars represent the standard deviation from at least three biological replicates.](2067f6){#fig6}

Discussion {#s18}
==========

Here, we developed a cloning-free CRISPR/Cas9 method based on gap repair in fission yeast cells. Previously, gap-repair-based CRISPR/Cas9 procedures have been developed in budding yeast to achieve cloning-free genome editing ([@bib22]; [@bib34]). The gapped plasmids used in those studies contain intact selection markers and thus, if recircularize through NHEJ-mediated DSB repair, can transform budding yeast cells without incorporating the sgRNA insert. Indeed, one of the studies reported a high background transformation efficiency when the sgRNA insert was omitted ([@bib34]). In theory, this problem can be mitigated in budding yeast by using gapped plasmids with blunt ends, as the budding yeast NHEJ machinery cannot efficiently recircularize linearized plasmids bearing blunt ends ([@bib3]). However, such a remedy is not applicable to fission yeast, because gapped plasmids with either cohesive or blunt ends, if containing intact selection markers, can transform fission yeast cells as efficiently as circular plasmids ([@bib19]; [@bib50]; [@bib33]). The split-marker design we implemented in this study successfully circumvents this background transformation issue and should be useful to other organisms where NHEJ-mediated plasmid recircularization can compete with gap repair.

It was reported that, in budding yeast, the selection of a gap-repair outcome during transformation enhanced the efficiency of recombination-mediated genome editing, possibly due to an enrichment of cells in S/G2/M phase of the cell cycle, which have a stronger homologous recombination activity than cells in the G1 phase of the cell cycle ([@bib22]). We do not know whether such an enhancement effect occurs in fission yeast, because in the only head-to-head comparison between the gap-repair-based method and the circular-plasmid-based method ([Figure 2](#fig2){ref-type="fig"}), both methods achieved near saturating levels of editing efficiency. We suspect that such an effect, if exists, may not be as pronounced as in budding yeast, because fission yeast has a much shorter G1 phase than budding yeast and most of the fission yeast cells in an asynchronous culture are in the G2 phase. On the other hand, we did uncover an unexpected advantage of the gap-repair-based method, as it yielded a more than 10 times higher transformation efficiency compared to the circular-plasmid-based method ([Figure 2](#fig2){ref-type="fig"}). We speculate that the delay of sgRNA (and perhaps also Cas9) expression in the gap-repair procedure, due to the time needed to complete gap repair, may allow the cells to first recover from the stress of the transformation procedure before encountering the stresses generated by Cas9 and sgRNA.

One practical issue of using Cas9 in fission yeast is its sgRNA-independent growth-inhibition effect, which results in a longer-than-usual incubation time for transformant colonies to form (6-8 days with the split-*ura4* system). The sgRNA-independent cytotoxicity of Cas9 has been reported in a number of organisms, including the bacteria *Clostridium pasteurianum* ([@bib38]) and *Clostridium acetobutylicum* ([@bib4]), the cyanobacterium *Synechococcus elongatus* ([@bib49]), the budding yeast *Saccharomyces cerevisiae* ([@bib43]; [@bib41]; [@bib17]), the fission yeast *S. pombe* ([@bib24]), and the single-cell alga *Chlamydomonas reinhardtii* ([@bib26]). In the cases of *S. pombe* and *Chlamydomonas reinhardtii*, it has been shown that the cytotoxicity is independent of the Cas9 nuclease activity ([@bib26]; [@bib7]). We have attempted to circumvent this issue by using weaker promoters or repressible promoters to drive the expression of Cas9, but have thus far failed to identify a condition where reduced cytotoxicity is not accompanied by a severe reduction of editing efficiency (data not shown). Alternative strategies, such as appending an inducible degron to Cas9 ([@bib45]), may need to be explored in the future to further improve the application of CRISPR/Cas9-based genome editing in *S. pombe*.
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